by Ochsner Health System Credit: Pixabay/CC0 Public Domain Ochsner Health physicians Dr. Richard Zweifler and Dr. Joseph Tarsia are co-authors on a post hoc analysis carried out in the ARCADIA randomized clinical trial, comparing the effectiveness of apixaban versus aspirin in preventing adverse clinical outcomes in patients with a history of cancer and cryptogenic stroke....
Tag: <span>low-dose apixaban</span>
Post
Venous thromboembolism: Less recurrencies with low-dose apixaban compared to discontinuation of the anticoagulant after negative D-dimer
FONDAZIONE ARIANNA ANTICOAGULAZIONE IMAGE: 6° CONVEGNO DI FONDAZIONE ARIANNA E ANTICOAGULAZIONE.IT CREDIT: SMC MEDIA SRL Bologna 8 April 2022 – Patients who have suffered from a first episode of unprovoked venous thromboembolism (VTE) have an eight times higher risk of recurrence if they stop treatment after repeated negative D-dimer tests, instead of continuing with low-dose anticoagulant (apixaban)....